A detailed history of Texas Bank & Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Texas Bank & Trust CO holds 6,603 shares of NVS stock, worth $868,624. This represents 0.32% of its overall portfolio holdings.

Number of Shares
6,603
Previous 7,203 8.33%
Holding current value
$868,624
Previous $872 Million 2.85%
% of portfolio
0.32%
Previous 0.35%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

SELL
$113.5 - $129.73 $68,100 - $77,838
-600 Reduced 8.33%
6,603 $847 Million
Q2 2025

Aug 05, 2025

SELL
$101.96 - $121.01 $51,387 - $60,989
-504 Reduced 6.54%
7,203 $872 Million
Q1 2025

May 15, 2025

SELL
$97.14 - $115.57 $8,839 - $10,516
-91 Reduced 1.17%
7,707 $859 Million
Q4 2024

Feb 14, 2025

BUY
$96.78 - $117.18 $754,690 - $913,769
7,798 New
7,798 $759 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Texas Bank & Trust CO Portfolio

Follow Texas Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Texas Bank & Trust CO with notifications on news.